The Canadian Generic Pharmaceutical Association's mission is to promote an environment which supports and enhances the provision of affordable generic and biosimilar medicines to Canadians and patients around the world through research, development and manufacturing of pharmaceuticals and fine chemicals in Canada. Through its Biosimilars Canada division, it provides leadership in educating Canadian stakeholders about biosimilar medicines, and advocating for policies that support their approval, reimbursement and market acceptance.
JAMES KEON, PRESIDENT
Address:
501 - 4100 Yonge Street
Toronto, ON M2P 2B5
Canada
Telephone number:
416-223-2333
Fax number:
416-223-2425
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
Canadian Generic Pharmaceutical Association (CGPA)/L'Association canadienne du médicament générique (ACMG) | 2008-08-01 | current |
CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION (CGPA) | 2008-08-01 | 2008-08-01 |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Program Specialist
Canadian Food Inspection Agency, Health Protection Branch |
October 1987 to October 1998 | Not a designated office |
Food and Drug Inspector
Health Canada, Health Protection Branch |
February 1982 to October 1987 | Not a designated office |
Food Chemistry Technician
Health Canada, Health Protection Branch |
August 1981 to February 1982 | Not a designated office |
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Special Assistant, Communications
House of Commons, Progressive Conservative's Leader Office |
March 2000 to January 2001 | Not a designated office |
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Program Specialist
Canadian Food Inspection Agency, Health Protection Branch |
October 1987 to October 1998 | Not a designated office |
Food and Drug Inspector
Health Canada, Health Protection Branch |
February 1982 to October 1987 | Not a designated office |
Food Chemistry Technician
Health Canada, Health Protection Branch |
August 1981 to February 1982 | Not a designated office |
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Acting Director General
Industry Canada, Consumer Affairs |
1994 to 1994 | Not a designated office |
Regional Director
Consumer and Corporate Affairs, B.C. and Yukon |
1991 to 1993 | Not a designated office |
Director
Consumer and Corporate Affairs, Intellectual Property |
1988 to 1991 | Not a designated office |
Senior Analyst
Consumer and Corporate Affairs, Consumer Affairs |
1987 to 1988 | Not a designated office |
Policy Analyst
Consumer and Corporate Affairs, Intellectual Property |
1978 to 1986 | Not a designated office |
Research Analyst
Statistics Canada, Industry Statistics |
1977 to 1978 | Not a designated office |